- /
- Supported exchanges
- / US
- / GRAL.NASDAQ
GRAIL, LLC (GRAL NASDAQ) stock market data APIs
GRAIL, LLC Financial Data Overview
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring. The company was incorporated in 2015 and is headquartered in Menlo Park, California.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with GRAIL, LLC (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get GRAIL, LLC data using free add-ons & libraries
Get GRAIL, LLC Fundamental Data
GRAIL, LLC Fundamental data includes:
- Net Revenue: 165 M
- EBITDA: -378 488 992
- Earnings Per Share: -9
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-08-05
- EPS/Forecast: -2.91
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
GRAIL, LLC News
New
Catalyst Watch: Jobs report, Trump AI talks, and ticking fee time for Paramount
[Skyline. Office skyscraper in New York City, Manhattan] ultramarinfoto Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more abou...
Beyond GLP-1 injectables, who wins the next phase for obesity drugs?
[Ozempic Insulin injection pen] CR/iStock via Getty Images INVESTORS SHOULD KNOW: The obesity drug market is undergoing a structural shift, moving beyond the initial injectable GLP-1 franchise. Now, ...
GRAIL's Galleri test wins endorsement from FDA panel
* A panel of US FDA advisors voted that there is reasonable evidence that GRAIL’s (GRAL [https://seekingalpha.com/symbol/GRAL]) multi-cancer early detection blood test Galleri is effective. The vo...
GRAIL to Present at Morgan Stanley's 24th Annual Global Healthcare Conference
MENLO PARK, Calif., Aug. 31, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.